Next Article in Journal
Structural Characterization and Interaction with RCA120 of a Highly Sulfated Keratan Sulfate from Blue Shark (Prionace glauca) Cartilage
Previous Article in Journal
Astaxanthin Restrains Nitrative-Oxidative Peroxidation in Mitochondrial-Mimetic Liposomes: A Pre-Apoptosis Model
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Terpenoids from the Soft Coral Sinularia sp. Collected in Yongxing Island

1
Key Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Yushan Road 5, Qingdao 266003, China
2
Laboratory of Marine Drugs and Biological Products, National Laboratory for Marine Science and Technology, Qingdao 266235, China
3
College of Chemistry and Chemical Engineering, Ocean University of China, Songling Road 238, Qingdao 266100, China
4
Nationaal Natuurhistorisch Museum, P.O. Box 9517, 2300 BA Leiden, The Netherlands
5
National Museum of Marine Biology and Aquarium, Pingtung 94450, Taiwan
6
Graduate Institute of Marine Biology, National Dong Hwa University, Pingtung 94450, Taiwan
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Mar. Drugs 2018, 16(4), 127; https://doi.org/10.3390/md16040127
Submission received: 20 March 2018 / Revised: 8 April 2018 / Accepted: 10 April 2018 / Published: 13 April 2018

Abstract

:
Three new sesquiterpenoids (sinuketal (1), sinulins A and B (2 and 3)) and two new cembranoids (sinulins C and D (4 and 5)), as well as eight known sesquiterpenoids (6–13) and eight known cembranoids (14–21), were isolated from the Xisha soft coral Sinularia sp. Their structures were elucidated by extensive spectroscopic analysis. Compound 1 possesses an unprecedented isopropyl-branched bicyclo [6.3.0] undecane carbon skeleton with unique endoperoxide moiety, and a plausible biosynthetic pathway of it was postulated. According to the reported biological properties of endoperoxide, the antimalarial, cytotoxic, antiviral, and target inhibitory activities of 1 were tested. Compound 1 showed mild in vitro antimalarial activity against Plasmodium falciparum 3D7, weak cytotoxic activities toward Jurkat, MDA-MB-231, and U2OS cell lines, inhibitory effects against influenza A viruses H1N1 and PR8, as well as mild target inhibitory activity against acetylcholinesterase. The other compounds were evaluated for cytotoxicities against HeLa, HCT-116, and A549 tumor cell lines and target inhibitory activities against protein tyrosine phosphatase 1B (PTP1B). Compound 20 exhibited cytotoxicities against HeLa and HCT-116, and compounds 5, 11, and 15 showed mild target inhibitory activities against PTP1B.

Graphical Abstract

1. Introduction

Alcyonacean octocorals have been recognized as an important source of marine secondary metabolites with a vast array of molecular architectures and diverse bioactivities [1]. As one of the most widely distributed alcyonacean corals, the genus Sinularia consists of almost 170 species [2], of which more than 50 have been chemically examined [3]. A wide range of bioactive metabolites—including sesquiterpenoids, diterpenoids, polyhydroxysterols, glycosides, ceramides, and cyclopentenone and butanolide derivatives—from this genus have been described [4,5]. As part of our ongoing search for bioactive compounds from soft corals of the South China Sea [6,7], we collected the soft coral Sinularia sp. off the coast of Yongxing Island of Xisha Islands. Herein, we report the chemical investigation of this specimen, which led to the isolation of 3 new sesquiterpenoids (sinuketal (1), sinulins A and B (2 and 3)), 2 new cembranoids (sinulins C and D (4 and 5)) (15, Figure 1), and 16 known terpenoids (621). Compound 1 is the first example of marine-originated isopropyl branched bicyclo [6.3.0.] undecane sesquiterpenoid, which is different from tehranolide, the only similar analogue, because of the position of the methyl and isopropyl groups [8]. As the endoperoxide moiety represents a special pharmacophore [9,10], antimalarial (against Plasmodium falciparum 3D7), immune-suppressive (on interleukin (IL-2) secretion), cytotoxic (toward human acute T-cell leukemia (Jurkat), human breast carcinoma (MDA-MB-231), human osteosarcoma cells (U2OS), and human lung carcinoma (A549)), antiviral (against influenza A viruses (H1N1) and (PR8)), and target inhibitory activities (on receptor tyrosine kinase c-Met and acetylcholinesterase) of compound 1 were evaluated. In addition, the other compounds were evaluated for their cytotoxicities (against human cervical epitheloid carcinoma (HeLa), human colon carcinoma (HCT-116), and human lung epithelial carcinoma (A549) tumor cell lines) and target inhibitory activities (against protein tyrosine phosphatase 1B (PTP1B)).

2. Results and Discussion

Sinuketal (1) was obtained as a light-yellow oil. The molecular formula was determined as C15H24O3 by high-resolution electrospray ionization mass spectrometry (HRESIMS) peak at m/z 253.1800 [M + H]+ (calcd. 253.1798), indicating four degrees of unsaturation. The infrared radiation (IR) spectrum showed the presence of a hydroxyl group (3321 cm−1), which was supported by an electrospray ionization mass spectrometry (ESIMS) fragment at m/z 235 [MH − H2O]+. The 1H NMR spectrum of 1 (Table 1) showed the presence of two methyl doublets (δH 0.89 (3H, d, J = 6.7 Hz) and 0.95 (3H, d, J = 6.7 Hz)), an AX coupling system (δH 2.28 (1H, d, J = 13.4 Hz) and 3.14 (1H, d, J = 13.4 Hz)), and two terminal olefinic protons (δH 4.90 (1H, brs) and 4.93 (1H, brs)). Its 13C NMR and DEPT spectroscopic data (Table 1) exhibited a total of 15 carbon resonances, including 2 methyls, 6 sp3 methylenes, 3 sp3 methines, 2 sp3 oxygenated unprotonated carbons (including an anomeric carbon δC 107.4 (C)), and 1 terminal double bond (δC 113.0 (CH2) and 149.4 (C)), accounting for one degree of unsaturation. The above NMR signals suggested the structure of a tricyclic sesquiterpenoid. All the connections of H and protonated C were assigned by detailed analysis of heteronuclear multiple quantum correlation (HMQC) and heteronuclear multiple-bond correlation (HMBC) spectra. The 1H-1H correlation spectroscopy (1H-1H COSY) experiment displayed two spin systems, H2-6/H2-7 and H2-2/H2-1/H-11(H-12/H3-13(H3-14))/H-10/H2-9 (Figure 2). This was further supported by HMBC correlations from H2-7 to C-6 and from H3-14 to C-13, C-12 and C-11, from H-11 to C-1, C-9 and C-10, and from H2-1 to C-2 (Figure 2). HMBC correlations from H-1a and H2-2 to C-3 and from H-9α and H-10 to C-3 indicated the presence of a cyclopentane moiety. HMBC correlations from H2-15 to C-9 and C-7, from H2-7 to C-8, from H-6α and H2-7 to C-5, from H-6β to C-4, from H-4β to C-3, C-5 and C-10, and from H-4α to C-6 implied the cyclooctane moiety. Consequently, a 5/8 fused bicyclic system was established, which was further supported by HMBC correlations from H-4β to C-2 and from H-11 to C-9. Considering the last degree of unsaturation according to molecular formula, an AX coupling methylene, and downfield chemical shifts of oxygenated C-3 (δ 98.0) and anomeric C-5 (δ 107.4), a (C-3)–O–O–(C-5)–OH moiety should be present. Thus, the planar structure of 1 was established as shown in Figure 2.
The relative configuration of 1 was established by nuclear Overhauser effect spectroscopy (NOESY) experiment (Figure 3) in combination with conformational analysis, and density functional theory-NMR (DFT-NMR). A trans configuration for H-11 and H-10 in the cyclopentane ring was deduced from the NOE correlations of H-10 with H-12 and H3-13, which was consistent with the absence NOE effect of H-10 with H-11. The endoperoxide group should be on the same side of the cyclooctane ring, owing to unfavorable distortions on the basis of molecular model analysis. NOE correlations of H-11 with H-9α and of H-9α with H-4α indicated cis-fused bicyclo [6.3.0] undecane. The above evidence suggested two stereochemical candidates of 1 (1a: 3R,5R,10S,11S; 1b: 3S,5S,10R,11R). In order to gain further support for determination of the relative configuration of 1, 13C NMR chemical shifts were calculated by the Gaussian 09 program package. The stable conformations of all the eight isomers of 1 were calculated by DFT gauge-including atomic orbitals (GIAO) model at RB3LYP/6-31+G(2d,p) level [11]. Tables S3 and S4 show the experimental and calculated 13C chemical shifts (relative to TMS-resonance calculated at the same level), as well as the calculated data after linear regression scaling. As a result, the calculation data of 1a (Figure 4a) and its enantiomer 1b gives the most reasonable correlation coefficient R2 value of 0.997, with mean absolute error 1.5 ppm and maximum absolute error 5.4 ppm (at C-15). Thus, the GIAO-based 13C NMR chemical shifts calculation data strongly supported the assigned carbon and relative configuration of 1. Therefore, the relative configuration of 1 was unambiguously assigned as 3R*,5R*,10S*,11S*.
The absolute configuration of 1 was determined by time-dependent density functional theory calculation of electronic circular dichroism (TDDFT/ECD) method with the basis set RB3LYP/DGDZVP [12,13,14]. The measured ECD spectrum of 1 in methanol exhibited a negative Cotton effect (CE) at 238 nm, matching well with the calculated ECD spectra for 1a (Figure 4b). Therefore, the absolute configuration of (−)-1 was established as 3R,5R,10S,11S.
Structurally, compound 1 has a previously unknown sesquiterpenoid skeleton; for this new skeleton we propose the name “sinulane”. As shown in Scheme 1, a biogenetic pathway of 1 can plausibly be retrospect to the isodaucyl cation, the biosynthetic precursor of isolated (7), which can be traced biogenically back to the germacryl cation and farnesyl diphosphate (FPP) [15,16]. The carbocation of the isodaucyl cation can be discharged by enzyme-catalyzed cyclization to generate intermediate A [17], rather than by quenching with a nucleophile to form compound 7. Then, oxidation of intermediate A yields intermediate B, which subsequently undergoes oxygen-mediated hydroperoxidation [15,18] and concerted ring expansion to form hydroperoxide intermediate C. Finally, the conversion from intermediate C into 1 could be carried out by intramolecular semi-acetalization reaction [19] and Wagner–Meerwein 1,3-hydride shift.
Sinulin A (2), a C-10 epimer of co-isolated 10-oxo-isodauc-3-en-15-al (6) [20], was obtained as a colorless oil. The molecular formula of C15H22O2 and five degrees of unsaturation were inferred from its HRESIMS at m/z 257.1514 [M + Na]+ (calcd. 257.1512). The 13C NMR spectra (Table 2) of 2 indicated 15 carbon signals, and a DEPT experiment exhibited the presence of three methyls, four sp3 methylenes, three sp3 methines, one sp3 quaternary, two sp2 methines, and two sp2 quaternary carbons. The 13C NMR and 1H NMR spectra (Table 2) implied the presence of an α,β-unsaturated conjugated aldehyde (δH 6.78 (1H, dd, J = 4.8, 1.8 Hz) and 9.49 (1H, s); δC 157.4 (CH), 143.7 (C) and 192.7 (CH)) and a ketone (δC 213.2 (C)). Thus, a bicyclic sesquiterpenoid structure of 2 was revealed. From the 1H-1H COSY spectrum (Figure 2), two partial structures of consecutive proton systems, H2-5/H2-6 and H-8/H-9/H-10/(H-11/H3-12(H3-13))/H2-1/H2-2, were established. Key HMBC correlations from H3-14 to C-2, C-3, C-4 and C-9, from H2-5 to C-4, from H-15 to C-6 and C-7, and from H-8 to C-15 assembled the planar structure of 2 (Figure 2), which has a isodaucane skeleton. The relative configuration of 2 was established from NOE experiment (Figure 3). Irradiation of H3-14 caused a clear NOE effect with H-9 and H-10, and no NOE effect with H-11, H3-12, and H3-13, which suggested the same orientation of H3-14, H-9, and H-10. The absolute configuration of 2 was deduced by TDDFT-ECD calculations. The experimental ECD curve of (−)-2 matched well with the calculated ECD curve of 3R,9R,10R (Figure 5a).
Sinulin B (3) was isolated as a colorless, amorphous solid with molecular formula of C15H24O3 on the basis of its HRESIMS at m/z 253.1798 [M + H]+ (calcd. 253.1798), requiring four degrees of unsaturation. 1H and 13C NMR spectral data (Table 3) suggested the presence of a ketone (δC 213.0 (C)) and a terminal double bond (δH 5.28 (1H, s) and 5.05 (1H, s); δC 142.9 (C) and 110.6 (CH2)). According to the molecular formula, 13C NMR and DEPT spectroscopic data (Table 3), and the functionalities mentioned above, compound 3 was suggested to be a bicyclic sesquiterpenoid. The 1H-1H COSY correlations H2-2/H2-3 and H-5/H-6/H-7/H2-8/H2-9 together with the key HMBC correlations from H3-14 to C-1, C-5, C-9, and C-10, from H3-13 to C-7, C-11, and C-12, from H2-15 to C-3, C-4 and C-5, and from H2-2 and H2-3 to C-1 (Figure 2) established the planar structure of 3 (Figure 2), with an eudesmane skeleton. The relative configuration of 3 was determined on the basis of NOESY spectrum (Figure 3). NOE correlations of H-6 with H3-13 and H3-14 revealed that H-6, H3-13, and H3-14 were on the same face of the molecule. In addition, NOE correlation of H-7 with H-5 implied H-5 was on the opposite side of the molecule. The absolute configuration of (+)-3 was assigned as 5S,6R,7R,10R on the basis of the experimental ECD curve of 3, and gave good overall mirror-imagine agreement with the calculated ECD curve of 5S,6R,7R,10R (Figure 5b).
The molecular formula of sinulin C (4), a colorless oil, was established as C23H30O8 from the HRESIMS data [M + Na]+ at m/z 457.1836 (calcd. 457.1833). Analysis of the 1H and 13C NMR (Table 4) data indicated the presence of an isopropenyl group (δH 4.87 (1H, s), 4.79 (1H, s), and 1.81 (3H, s); δC 145.9 (C), 111.4 (CH2), and 20.8 (CH3)), a trisubstituted furane ring (δH 6.63 (1H, s); δC 161.0 (C), 149.0 (C), 114.6 (C), and 112.2 (CH)), two methyl esters (δH 3.79 (3H, s) and 3.72 (3H, s); δC 164.0 (C), 167.3 (C), 51.4 (–OCH3), and 52.1 (–OCH3)), a methoxy group (δH 3.26 (3H, s); δC 57.8 (–OCH3)), a ketone (δC 208.6 (C)), a quaternary methyl (δH 1.35 (3H, s); δC 27.9 (CH3)) and a trisubstituted double bond (δH 6.96 (1H, dd, J = 11.0, 4.0 Hz); δC 144.1 (CH) and 125.1 (C)). Their positions were confirmed by HMBC correlations from H2-16 and H3-17 to C-1, from H2-2 to C-3 and C-4 and from H-7 to C-6, from H3-21 to C-18, from H3-23 to C-20, from H3-22 to C-7, from H2-9 and H2-11 to C-10, from H3-19 to C-8, and from H2-11 to C-12 and C-13 (Figure 2), respectively. These data together with 1H-1H COSY correlations H-13/H2-14/H-1/H2-2 (Figure 2), established the planar structure of 4 as a furanocembranolide, which is same as the known compound pambanolide C [21]. Per the NOESY experiment shown in Figure 3, the NOE correlation of H-11b with H-14a indicated the 12E olefin. NOE correlations of H3-19 with H-7 and H-9α and of H-9β with H-1 indicated H3-19 and H-7 were on the same face of the molecule and on the opposite of H-1.
HRESIMS of sinulin D (5), a colorless oil, showed a pseudomolecular ion peak [M + H]+ at m/z 363.1801 (calcd. 363.1802), consistent with the molecular formula C20H26O6, and eight degrees of unsaturation. 13C NMR and DEPT spectrum (Table 5) showed the presence of three ketones (δC 207.1 (C), 212.1(C), and 205.7 (C)), an isopropenyl group (δH 4.95 (1H, s), 4.75 (1H, s), and 1.75 (3H, s); δC 144.9 (C), 112.2 (CH2), and 21.2 (CH3)), and one α,β-unsaturated methyl ester (δH 6.80 (1H, dd, J = 7.0, 7.0 Hz), and 3.71 (CH3, s); δC 140.9 (CH), 128.6 (C), 167.3 (C), and 52.0 (CH3)), implying bicyclic structure of 5. The 1H-1H COSY correlations H-13/H2-14/H-1/H2-2 and H2-4/H-5 with the assistance of key HMBC correlations from H3-17 to C-1, C-15, and C-16, from H2-2 and H-5 to C-3, from H-5 and H2-7 to C-6, from H3-18 to C-7, C-8, and C-9, from H2-9 and H2-11 to C-10, and from H-13 to C-11, C-12, and C-19 (Figure 2) established the same norcembrene planar structure as co-isolated norcembrene 5 (16) [22]. The relative configuration of 5 was deduced by the NOESY experiment (Figure 3). The NOE correlation of H-11b with H2-14 indicated the 12E olefin. Key NOE correlations of H3-18 with H-7α, of H-7β with H-5, of H-4β with H-5 and H-2β, and of H-2β with H-1 suggested H-1 and H-5 were on the same face of the molecule and on the opposite of H3-18.
The known compounds were identified as (−)-10-oxo-isodauc-3-en-15-al (6) [20], (3R,4R,9R,10S)-isodauc-7-ene-4β,15-diol (7) [23], (3R,4R,9S,10S)-isodauc-7-ene-4β,15-diol (8) [24,25], (3S,4S,9R,10S)-isodauc-7-ene-4β,15-diol (9) [24,25], 1β,6α-dihydroxy-4(15)-eudesmene (10) [26], 15-hydroxy-α-cadinol (11) [27], 10-O-methyl-alismoxide (12) [28], guaianediol (13) [29], (1R,3S)-cembra-4,7,11,15-tetraen-3-ol (14) [30], (1R,3S,4S,7E,11E)-3,4-epoxycembra-7,11,15-triene (15) [30], norcembrene 5 (16) [22], norcembrenolide C (17) [31], sinularcasbane O (18) [32], scabrolide F (19) [32], 5-episinuleptolide (20) [22,33,34], and sinuleptolide (21) [33,34] (Figure 6). These compounds were identified by comparison of their NMR spectroscopic data with those reported in the literature.
According to the reported biological properties of endoperoxide [9,10], sinuketal (1) was tested for antimalarial (against P. falciparum 3D7), immune-suppressive (on interleukin (IL-2) secretion), cytotoxic (toward Jurkat, MDA-MB-231, U2OS, and A549 cell lines), antiviral (against influenza A viruses (H1N1) and (PR8)), and target inhibitory activities (on c-Met and acetylcholinesterase). As a result, compound 1 showed mild in vitro antimalarial activity against P. falciparum 3D7 (IC50 = 80 μM, 10 nM dihydroartemisinine as positive control), weak cytotoxic activities toward Jurkat, MDA-MB-231, and U2OS cell lines (IC50 = 24.9, 32.3, and 41.7 μM, respectively), inhibitory effects with IC50 values of 172 μM and 443 μM against influenza A viruses H1N1 and PR8, respectively (ribavirin as positive control, IC50 = 103 μM), and 20.2% inhibition rate against acetylcholinesterase (at 50 μg/mL, tacrine as positive control with inhibition rate 75.7% at 66 μg/L). The other compounds were evaluated for cytotoxicities against HeLa, HCT-116, and A549 tumor cell lines and target inhibitory activities against PTP1B. Compound 20 exhibited cytotoxicities against HeLa and HCT-116 with IC50 values of 11.6 and 33.3 μM. Compounds 5, 11, and 15 showed mild target inhibitory activities against PTP1B with IC50 values of 47.5, 22.1, and 12.5 mM (sodium orthovanadate as positive control, IC50 = 881 μM).

3. Materials and Methods

3.1. General Experimental Procedures

Optical rotations were measured on a Jasco P-1020 digital polarimeter (Jasco International Co. Ltd., Tokyo, Japan). UV spectra were recorded on a Beckman DU640 spectrophotometer (Beckman Instruments, Brea, CA, USA). CD spectra were obtained on a Jasco J-810 spectropolarimeter (Jasco International Co., Ltd., Tokyo, Japan). IR spectra were taken on a Nicolet NEXUS 470 FT-IR spectrophotometer (Thermo Nicolet Corporation, Madison, Wisconsin, USA) in KBr discs. NMR spectra were measured by Bruker AVANCE III 500 spectrometers (Bruker, Karlsruhe, Germany), 500 MHz for 1H NMR and 125 MHz for 13C NMR in CDCl3, chemical shifts δ in ppm referred to the solvent peaks at δH 7.26 and δC 77.0 for CDCl3, and coupling constant J in Hz. HRESIMS spectra were measured on Micromass Q-Tof Ultima GLOBAL GAA076LC mass spectrometers (Waters Asia, Ltd., Singapore) or 1290 Infinity II UHPLC/6530 Q-TOF MS (Agilent Technologies Inc., Palo Alto, CA, USA). HPLC separation was performed on a Waters 2695/2998 instrument (Waters Corporations, Milford, MA, USA) with DAD detector, equipped with a semipreparative reversed-phased column (YMC-Pack ODS-A, 250 × 10 mm, 10 μm) or an analytic reversed-phased column (ZORBAX Eclipse XDB-C18, 250 × 4.6 mm, 5 μm). Silica gel ((200–300 mesh, 300–400 mesh, and silica gel H), Qingdao Marine Chemical Inc., Qingdao, China) and Sephadex LH-20 (Amersham Pharmacia Biotech AB, Uppsala, Sweden) were used for column chromatography, and precoated silica gel plates (GF254, Qingdao Marine Chemical Inc., Qingdao, China) were used for TLC, and spots visualized by heating SiO2 plates sprayed with 10% H2SO4 in EtOH.

3.2. Animal Material

All collections of the soft coral Sinularia sp. were carried out in Yongxing Island (16°50′ N, 112°20′ E) of Xisha Islands in the South China Sea in November 2012 and were frozen immediately. The specimen was identified by Dr. Leen van Ofwegen, a co-author of this paper. The voucher specimen (No. XS-2012-04) was deposited at State Key Laboratory of Marine Drugs, Ocean University of China, China.

3.3. Extraction and Isolation

The frozen animals of Sinularia sp. (5.2 kg, wet weight; 1.4 kg, dry weight) were cut into pieces and extracted with MeOH four times (7 days each time) assisted by ultrasound at room temperature. After removal of solvent in vacuo, the combined organic extracts were desalted four times by re-dissolving with absolute methanol. The desalted residue (114 g) was subjected to vacuum liquid chromatography (VLC), eluting with a gradient of petroleum/acetone (1/0 to 1/1) and subsequently CH2Cl2/MeOH (20/1 to 0/1), to yield 10 fractions. Fraction 1 was chromatographed on silica gel eluting with a gradient of petroleum/acetone (1/0 to 0/1) to yield seven subfractions (F11–F17). Subfraction F12 was purified in a silica gel column, using petroleum/acetone (200/1), and then was isolated by semipreparative HPLC (MeOH/H2O, 82/18) to yield 14 (7.0 mg). Fraction 2 was applied to open octadecyl silane (ODS) column chromatography eluting by MeOH/H2O (70–100%) to obtain F21–F24. Subfraction F22 was refined in a silica gel column using petroleum/EtOAc (60/1), then further isolated on ODS column chromatograph using MeOH/H2O (40–65%) to give three fractions (F2221–F2223). F2222 was primarily purified by semipreparative HPLC (MeOH/H2O, 60/40) to yield a mixture of 2 and 6, which was elucidated by NMR spectroscopic analysis, and then separated by chiral HPLC (n-hexane/isopropanol, 98/2) on chiral Daicle Chiralpack IC column (250 × 4.6 mm, 5 μm) to give 2 (2.0 mg) and 6 (2.4 mg). Subfraction F23 was purified by silica gel column using petroleum/EtOAc (80/1), and then was further separated by semipreparative HPLC (MeOH/H2O, 80/20) to yield 15 (3.4 mg). Fraction 3 was chromatographed on silica gel, eluting with a gradient of petroleum/acetone (50/1 to 5/1) to yield seven subfractions (F31–F37). Subfraction F33 was further separated to four fractions (F331–F334) by open-ODS column chromatography with a gradient of MeOH/H2O (50–100%). F332 was repurified with semipreparative HPLC (MeOH/H2O, 58/42) to afford 12 (27.2 mg). F333 was initially refined with semipreparative HPLC (MeOH/H2O, 60/40), and then further purified by Waters analytical HPLC (MeOH/H2O, 50/50) using an analytic reversed-phased column (4.6 × 250 mm, 5 μm) over 100 min, which yielded 1 (3.9 mg). Fraction 4 was chromatographed on a silica gel column with petroleum/acetone (30/1) to yield five subfractions (F41–F45). Subfraction F43 was purified by a silica gel column using petroleum/acetone (30/1) as eluent, and further purified by silica gel column chromatography (petroleum/acetone/EtOAc, 60/1/1), and open-ODS column chromatography (MeOH/H2O, 50–80%) to give five fractions (F43421–F43425). F43422 was further purified by open-ODS column chromatography (MeOH/H2O, 40–80%) and semipreparative HPLC (MeOH/H2O, 38/62) to yield 10 (2.4 mg). F43425 was further subjected to open-ODS column chromatography (MeOH/H2O, 70–100%) and semipreparative HPLC (MeOH/H2O, 60/40) to yield 4 (2.5 mg). Subfraction F44 was refined with semipreparative HPLC (MeOH/H2O, 60/40) to afford 16 (27.0 mg). Fraction 5 was chromatographed on silica gel eluting with petroleum/acetone (20:1), and then on silica gel eluting with CH2Cl2/MeOH (100:1) to obtain four fractions (F551–F554). F551 was applied to silica gel column eluting with petroleum/acetone (5/1) to afford F5511–F5515. F5513 was further purified by silica gel column (petroleum/acetone, 12/1), open-ODS column chromatography (MeOH/H2O, 30–45%), and semipreparative HPLC (MeOH/H2O, 35/65) to afford 5 (4.3 mg). F5514 was refined in a silica gel column using petroleum/acetone (7/1) and then further isolated on semipreparative HPLC using MeOH/H2O (41/59) to yield 17 (11.0 mg), 18 (9.1 mg), and 19 (4.0 mg). F552 was further subjected to open-ODS column chromatography (MeOH/H2O, 40%) and semipreparative HPLC (MeOH/H2O, 38/62) to yield 3 (1.5 mg) and 13 (33.7 mg). F553 was further purified by open-ODS column chromatography (MeOH/H2O, 40–80%), silica gel column (petroleum/acetone, 10/1), and semipreparative HPLC (MeOH/H2O, 53/47) to afford 8 (3.0 mg), 9 (3.0 mg), and 11 (9.5 mg). F554 was refined in a silica gel column using petroleum/acetone (6/1) and then further isolated on semipreparative HPLC using MeOH/H2O (58/42) to yield 7 (2.3 mg). Fraction 7 was separated to two fractions (F71 and F72) by Sephadex LH-20 (CH2Cl2/MeOH 1/1). Semipreparative HPLC of F72 using MeOH/H2O (30/70) afforded 20 (16.7 mg) and 21 (13.0 mg).
Sinuketal (1): light-yellow oil; [ α ] D 25 −46.3 (c 0.26, MeOH); IR (KBr) νmax 3321, 2958, 2931, 1709 cm−1; 1H and 13C NMR data, see Table 1; HRESIMS: m/z 253.1800 [M + H]+ (calcd. for C15H25O3, 253.1798).
Sinulin A (2): colorless oil; [ α ] D 20 −28.1 (c 0.10, MeOH); IR (KBr) νmax 2956, 2926, 2971, 1698, 1458, 1385, 1204 cm−1; 1H and 13C NMR data, see Table 2; HRESIMS: m/z 257.1514 [M + Na]+ (calcd. for C15H22O2Na, 257.1512).
Sinulin B (3): colorless amorphous solid; [ α ] D 25 +93.8 (c 0.10, MeOH); IR (KBr) νmax 3297, 2969, 2941, 1709, 1653, 1452, 1381 cm−1; 1H and 13C NMR data, see Table 3; HRESIMS: m/z 253.1798 [M + H]+ (calcd. for C15H25O3, 253.1798).
Sinulin C (4): colorless oil; [ α ] D 20 −52.0 (c 0.10, MeOH); IR (KBr) νmax 3447, 2932,1439, 1384, 1211, 1081 cm−1; 1H and 13C NMR data, see Table 4; HRESIMS: m/z 457.1836 [M + Na]+ (calcd. for C23H30O8Na, 457.1833).
Sinulin D (5): colorless oil; [ α ] D 25 +165.3 (c 0.10, MeOH); IR (KBr) νmax 3396, 2927, 2854, 1759, 1710, 1644, 1436, 1381, 1331, 1281, 1260, 1199, 1167, 1180 cm−1; 1H and 13C NMR data, see Table 5; HRESIMS: m/z 363.1801 [M + H]+ (calcd. for C20H26O6, 363.1802).

3.4. Computational Section

The quantum chemical calculations were carried out by Gaussian 09 [35] software (Gaussian Inc. Wallingford, CT, USA) using the density functional theory (DFT). The initial stereochemical structures were built with Spartan 10 software and first minimized based on molecular mechanics calculations. Then, conformational search was performed by Spartan 10 software using MMFF force filed, and conformers occurring within a 10 kcal/mol energy window from the global minimum were chosen for geometry optimization in the gas phase with the DFT method at the B3LYP/DGDZVP level. The B3LYP/DGDZVP harmonic vibrational frequencies were further calculated to confirm their stability. The stable conformations were calculated by DFT GIAO model at RB3LYP/6-31+G(2d,p) level to calculate 13C NMR chemical shifts. In the ECD calculations, the spin-allowed excitation energies and rotatory (Rn) and oscillator strengths (fn) of the lowest excited states of stable conformers were calculated using TD-DFT method with the basis set RB3LYP/DGDZVP. Solvent effects of methanol solution were evaluated at the same DFT level by using the SCRF/PCM method in agreement with the experiment condition. Electronic transitions were expanded as Gaussian curves with a full width at half maximum (FWHM) for each peak of 0.32 eV. The ECD spectra were combined after Boltzmann weighting according to their population contribution.

3.5. Antimalarial Activity

The in vitro antimalarial activity was assessed against P. falciparum (3D7) using an SYBR-Green assay [36] with 10 nM dihydroartemisinine as positive control. Twelve diluted samples (5 µM, 10 µM, 20 µM, 40 µM, 80 µM, 100 µM, 200 µM, 400 µM, 800 µM, 1 mM, 2 mM, and 4 mM) were added to the test wells to obtain the 50% inhibiting concentration.

3.6. Immunosuppressive Activity

The determination of immunosuppressive activity of compound 1 on interleukin 2 (IL-2) secretion in Jurkat T-cells was performed as the literature reported [37], using DMSO and FK506 (Tacrolimus) as negative and positive controls, respectively.

3.7. Cytotoxic Activities

The cytotoxicities against Jurkat, MDA-MB-231, U2OS, HeLa, HCT-116, and A549 cell lines were assayed by MTT method [38] with Adriamycin as a positive control. All the cell lines were purchased from Shanghai Institute of Cell Biology (Shanghai, China).

3.8. Antiviral Activities

The antiviral activities against influenza A virus (H1N1) and (PR8) were evaluated by the CPE inhibition assay as the literature reported [39]. Ribavirin was used as positive control, and compounds with an inhibition rate of >70%, >50%, and <30% at 50 μg/mL were respectively regarded having strong, moderate, and weak activities.

3.9. Target Inhibitory Activities

Evaluation of the inhibitory effects on acetylcholinesterase was performed by the spectrophotometric method developed by Ellman with slight modifications as reported [40], and on c-Met and PTP1B by using the enzyme-linked immunosorbent assay (ELISA) methodology [41].

4. Conclusions

The chemical study of soft coral Sinularia sp. collected in Yongxing Island (China) led to the isolation of 3 new sesquiterpenoids (sinuketal (1), sinulins A and B (2 and 3)), 2 new cembranoids (sinulins C and D (4 and 5)), as well as 16 known terpenoids (621). Among them, compound 1 possesses an unprecedented isopropyl-branched bicyclo [6.3.0] undecane carbon skeleton with unique endoperoxide moiety. In bioactivity assays, compound 1 showed mild in vitro antimalarial activity against P. falciparum 3D7, weak cytotoxic activities toward Jurkat, MDA-MB-231, and U2OS cell lines, inhibitory effects against influenza A viruses H1N1 and PR8, as well as mild target inhibitory activity against acetylcholinesterase. Compound 20 exhibited cytotoxicities against HeLa and HCT-116, and compounds 5, 11, and 15 showed mild target inhibitory activities against PTP1B.

Supplementary Materials

The following are available online at https://www.mdpi.com/1660-3397/16/4/127/s1, animal material information of Sinularia sp., computational details of 13, and 1D and 2D NMR spectra of new compounds 15.

Acknowledgments

This work was supported by the National Natural Science Foundation of China (Grant Nos. 41476107, 41522605), AoShan Talents Program Supported by Qingdao National Laboratory for Marine Science and Technology (No. 2015ASTP), and the Shandong Natural Science Fund for Distinguished Young Scholars (JQ201606).

Author Contributions

Guo-Qiang Li, Ping-Lin Li and Ping-Jyun Sung conceived and designed the experiments; Leen van Ofwegen identified the soft coral species; Guo-Fei Qin and Yan-Ting Sun isolated and identified the compounds; Xu-Li Tang and Jing Zhang performed the biological tests; Xiang-Chao Luo performed the computational section; Guo-Fei Qin and Xu-Li Tang wrote the manuscript.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Blunt, J.W.; Carroll, A.R.; Copp, B.R.; Davis, R.A.; Keyzers, R.A.; Prinsep, M.R. Marine natural products. Nat. Prod. Rep. 2018, 35, 8–53. [Google Scholar] [CrossRef] [PubMed]
  2. World Register of Marine Species (WoRMS). Available online: http://www.marinespecies.org/aphia.php?p=taxlist (accessed on 9 February 2018).
  3. Chen, W.T.; Li, Y.; Guo, Y.W. Terpenoids of Sinularia soft corals: Chemistry and bioactivity. Acta Pharm. Sin. B 2012, 2, 227–237. [Google Scholar] [CrossRef]
  4. Lakshmi, V.; Kumar, R. Metabolites from Sinularia species. Nat. Prod. Res. 2009, 23, 801–850. [Google Scholar] [CrossRef] [PubMed]
  5. Shi, H.Y.; Yu, S.J.; Liu, D.; van Ofwegen, L.; Proksch, P.; Lin, W.H. Sinularones A–I, new cyclopentenone and butenolide derivatives from a marine soft coral Sinularia sp. and their antifouling activity. Mar. Drugs 2012, 10, 1331–1344. [Google Scholar] [CrossRef] [PubMed]
  6. Gong, K.K.; Tang, X.L.; Zhang, G.; Cheng, C.L.; Zhang, X.W.; Li, P.L.; Li, G.Q. Polyhydroxylated steroids from the South China Sea soft coral Sarcophyton sp. and their cytotoxic and antiviral activities. Mar. Drugs 2013, 11, 4788–4798. [Google Scholar] [CrossRef] [PubMed]
  7. Zhang, N.X.; Tang, X.L.; van Ofwegen, L.; Xue, L.; Song, W.J.; Li, P.L.; Li, G.Q. Cyclopentenone derivatives and polyhydroxylated steroids from the soft coral Sinularia acuta. Chem. Biodivers. 2015, 12, 273–283. [Google Scholar] [CrossRef] [PubMed]
  8. Rustaiyan, A.; Sigari, H.; Jakupovic, J.; Grenz, M. A sesquiterpene lactone from Artemisia diffusa. Phytochemistry 1989, 28, 2723–2725. [Google Scholar] [CrossRef]
  9. Casteel, D.A. Peroxy natural products. Nat. Prod. Rep. 1999, 16, 55–73. [Google Scholar] [CrossRef]
  10. Bu, M.; Yang, B.B.; Hu, L.M. Natural endoperoxides as drug lead compounds. Curr. Med. Chem. 2016, 23, 383–405. [Google Scholar] [CrossRef] [PubMed]
  11. Lodewyk, M.W.; Siebert, M.R.; Tantillo, D.J. Computational prediction of 1H and 13C chemical shifts: A useful tool for natural product, mechanistic, and synthetic organic chemistry. Chem. Rev. 2012, 112, 1839–1862. [Google Scholar] [CrossRef] [PubMed]
  12. Kim, S.Y.; Nagashima, H.; Tanaka, N.; Kashiwada, Y.; Kobayashi, J.; Kojoma, M. Hitorins A and B, hexacyclic C25 terpenoids from Chloranthus japonicus. Org. Lett. 2016, 18, 5420–5423. [Google Scholar] [CrossRef] [PubMed]
  13. Sun, Y.Z.; Kurtán, T.; Mándi, A.; Tang, H.; Chou, Y.; Soong, K.; Su, L.; Sun, P.; Zhuang, C.L.; Zhang, W. Immunomodulatory polyketides from a Phoma-like fungus isolated from a soft coral. J. Nat. Prod. 2017, 80, 2930–2940. [Google Scholar] [CrossRef] [PubMed]
  14. Li, X.; Li, X.D.; Li, X.M.; Xu, G.M.; Liu, Y.; Wang, B.G. Wentinoids A–F, six new isopimarane diterpenoids from Aspergillus wentii SD-310, a deep-sea sediment derived fungus. RSC Adv. 2017, 7, 4387–4394. [Google Scholar] [CrossRef]
  15. Dewick, P.M. Medicinal Natural Products: A Biosynthetic Approach, 3rd ed.; John Wiley and Sons, Publication: West Sussex, UK, 2009; pp. 210–217. ISBN 978-0-470-74168-9. [Google Scholar]
  16. Bülow, N.; König, W.A. The role of germacrene D as a precursor in sesquiterpene biosynthesis: Investigations of acid catalyzed, photochemically and thermally induced rearrangements. Phytochemistry 2000, 55, 141–168. [Google Scholar] [CrossRef]
  17. Nes, W.D. Biosynthesis of cholesterol and other sterols. Chem. Rev. 2011, 111, 6423–6451. [Google Scholar] [CrossRef] [PubMed]
  18. Czechowski, T.; Larson, T.R.; Catania, T.M.; Harvey, D.; Brown, G.D.; Graham, I.A. Artemisia annua mutant impaired in artemisinin synthesis demonstrates importance of nonenzymatic conversion in terpenoid metabolism. Proc. Natl. Acad. Sci. USA 2016, 113, 15150–15155. [Google Scholar] [CrossRef] [PubMed]
  19. Dai, P.; Trullinger, T.K.; Liu, X.J.; Dussault, P.H. Asymmetric synthesis of 1,2-dioxolane-3-acetic acids: Synthesis and configurational assignment of plakinic acid A. J. Org. Chem. 2006, 71, 2283–2292. [Google Scholar] [CrossRef] [PubMed]
  20. Moriyasu, M.; Takeuchi, S.; Ichimaru, M.; Nakatani, N.; Nishiyama, Y.; Kato, A.; Mathenge, S.G.; Juma, F.D.; ChaloMutiso, P.B. Pyrenes and pyrendiones from Uvaria lucida. J. Nat. Med. 2012, 66, 453–458. [Google Scholar] [CrossRef] [PubMed]
  21. Chitturi, B.R.; Tatipamula, V.B.; Dokuburra, C.B.; Mangamuri, U.K.; Tuniki, V.R.; Kalivendi, S.V.; Bunce, R.A.; Yenamandra, V. Pambanolides A–C from the South Indian soft coral Sinularia inelegans. Tetrahedron 2016, 72, 1933–1940. [Google Scholar] [CrossRef]
  22. Sato, A.; Fenical, W.; Zheng, Q.T.; Clardy, J. Norcembrene diterpenoids from Pacific soft-corals of the genus Sinularia (Alcyonacea; Octocorallia). Tetrahedron 1985, 41, 4303–4308. [Google Scholar] [CrossRef]
  23. Nishizawa, M.; Inoue, A.; Hayashi, Y.; Sastrapradja, S.; Kosela, S.; Iwashita, T. Structure of aphanamol I and II. J. Org. Chem. 1984, 49, 3660–3662. [Google Scholar] [CrossRef]
  24. Liu, H.B.; Zhang, C.R.; Dong, S.H.; Yang, S.P.; Sun, Q.; Geng, M.Y.; Yue, J.M. Sesquiterpenes from Dysoxylum oliganthum and Dysoxylum excelsum. J. Asian Nat. Prod. Res. 2012, 14, 224–234. [Google Scholar] [CrossRef] [PubMed]
  25. Chen, D.W.; Cheng, W.; Liu, D.; van Ofwegen, L.; Proksch, P.; Lin, W.H. Capillosananes S–Z, new sesquiterpenoids from the soft coral Sinularia capillosa. Tetrahedron Lett. 2014, 55, 3077–3082. [Google Scholar] [CrossRef]
  26. Hu, J.F.; Bai, S.P.; Jia, Z.J. Eudesmane sesquiterpenes from Artemisia eriopoda. Phytochemistry 1996, 43, 815–817. [Google Scholar] [CrossRef]
  27. Kuo, Y.H.; Chen, C.H.; Chien, S.C.; Lin, Y.L. Five new cadinane-type sesquiterpenes from the heartwood of Chamaecyparis obtusa var. formosana. J. Nat. Prod. 2002, 65, 25–28. [Google Scholar] [CrossRef] [PubMed]
  28. Jin, H.G.; Jin, Q.; Kim, A.R.; Choi, H.; Lee, J.H.; Kim, Y.S.; Lee, D.G.; Woo, E.R. A new triterpenoid from Alisma orientale and their antibacterial effect. Arch. Pharm. Res. 2012, 35, 1919–1926. [Google Scholar] [CrossRef] [PubMed]
  29. El Sayed, K.A.; Hamann, M.T. A new norcembranoid dimer from the Red Sea soft coral Sinularia gardineri. J. Nat. Prod. 1996, 59, 687–689. [Google Scholar] [CrossRef] [PubMed]
  30. Bowden, B.F.; Coll, J.C.; Mitchell, S.J.; Kazlauskas, R. Studies of Australian soft corals. XXIV. Two cembranoid diterpenes from the soft coral Sinularia facile. Aust. J. Chem. 1981, 34, 1551–1556. [Google Scholar] [CrossRef]
  31. Saitman, A.; Rulliere, P.; Sullivan, S.D.E.; Theodorakis, E.A. Total synthesis of norcembrenolide B and scabrolide D. Org. Lett. 2011, 13, 5854–5857. [Google Scholar] [CrossRef] [PubMed]
  32. Hegazy, M.E.F.; Mohamed, T.A.; Elshamy, A.I.; Al-Hammady, M.A.; Ohta, S.; Paré, P.W. Casbane diterpenes from Red Sea coral Sinularia polydactyla. Molecules 2016, 21, 308–315. [Google Scholar] [CrossRef] [PubMed]
  33. Ahmed, A.F.; Shiue, R.T.; Wang, G.H.; Dai, C.F.; Kuo, Y.H.; Sheu, J.H. Five novel norcembranoids from Sinularia leptoclados and S. parva. Tetrahedron 2003, 59, 7337–7344. [Google Scholar] [CrossRef]
  34. Tseng, Y.J.; Ahmed, A.F.; Dai, C.F.; Chiang, M.Y.; Sheu, J.H. Sinulochmodins A−C, three novel terpenoids from the soft coral Sinularia lochmodes. Org. Lett. 2005, 7, 3813–3816. [Google Scholar] [CrossRef] [PubMed]
  35. Frisch, M.J.; Trucks, G.W.; Schlegel, H.B.; Scuseria, G.E.; Robb, M.A.; Cheeseman, J.R.; Scalmani, G.; Barone, V.; Mennucci, B.; Petersson, G.A.; et al. Gaussian 09, Revision A.1; Gaussian: Wallingford, CT, USA, 2009. [Google Scholar]
  36. Smilkstein, M.; Sriwilaijaroen, N.; Kelly, J.X.; Wilairat, P.; Riscoe, M. Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening. Antimicrob. Agents Chemother. 2004, 48, 1803–1806. [Google Scholar] [CrossRef] [PubMed]
  37. Ren, Y.R.; Pan, F.; Parvez, S.; Fleig, A.; Chong, C.R.; Xu, J.; Dang, Y.; Zhang, J.; Jiang, H.; Penner, R.; et al. Clofazimine inhibits human Kv1.3 potassium channel by perturbing calcium oscillation in T lymphocytes. PLoS ONE 2008, 3, e4009. [Google Scholar] [CrossRef] [PubMed]
  38. Alley, M.C.; Scudiero, D.A.; Monks, A.; Hursey, M.L.; Czerwinski, M.J.; Fine, D.L.; Abbott, B.J.; Mayo, J.G.; Shoemaker, R.H.; Boyd, M.R. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res. 1988, 48, 589–601. [Google Scholar] [PubMed]
  39. Wang, W.; Zhang, P.; Yu, G.L.; Li, C.X.; Hao, C.; Qi, X.; Zhang, L.J.; Guan, H.S. Preparation and anti-influenza A virus activity of k-carrageenan oligosaccharide and its sulphated derivatives. Food Chem. 2012, 133, 880–888. [Google Scholar] [CrossRef]
  40. Liu, S.B.; Chen, H.Q.; Guo, Z.K.; Dong, W.H.; Wang, J.; Mei, W.L.; Dai, H.F. Phragmalin-type limonoids from the roots of Trichilia sinensis. RSC Adv. 2017, 7, 28994–29003. [Google Scholar] [CrossRef]
  41. Du, L.; Ai, J.; Li, D.H.; Zhu, T.J.; Wang, Y.; Knauer, M.; Bruhn, T.; Liu, H.B.; Geng, M.Y.; Gu, Q.Q.; et al. Aspergiolides C and D: Spirocyclic aromatic polyketides with potent protein kinase c-Met inhibitory effects. Chem. Eur. J. 2011, 17, 1319–1326. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Structures of compounds 15.
Figure 1. Structures of compounds 15.
Marinedrugs 16 00127 g001
Figure 2. 1H-1H COSY and selected key HMBC correlations of 15.
Figure 2. 1H-1H COSY and selected key HMBC correlations of 15.
Marinedrugs 16 00127 g002
Figure 3. Key NOE correlations of 15.
Figure 3. Key NOE correlations of 15.
Marinedrugs 16 00127 g003
Figure 4. (a) Correlation of experimental and calculated chemical shifts of 1a; (b) experimental and theoretical ECD spectra of 1.
Figure 4. (a) Correlation of experimental and calculated chemical shifts of 1a; (b) experimental and theoretical ECD spectra of 1.
Marinedrugs 16 00127 g004
Scheme 1. Plausible biosynthetic pathway of 1.
Scheme 1. Plausible biosynthetic pathway of 1.
Marinedrugs 16 00127 sch001
Figure 5. (a) Experimental and theoretical ECD spectra of 2; (b) experimental and theoretical ECD spectra of 3.
Figure 5. (a) Experimental and theoretical ECD spectra of 2; (b) experimental and theoretical ECD spectra of 3.
Marinedrugs 16 00127 g005
Figure 6. Structures of compounds 621.
Figure 6. Structures of compounds 621.
Marinedrugs 16 00127 g006
Table 1. NMR spectral data of compound 1.
Table 1. NMR spectral data of compound 1.
No.δH (J in Hz) aδC (Type) b1H-1H COSYHMBCNOE
1a
1b
1.72 (1H, m)
1.37 (1H, m)
28.0 (CH2)H-1b, 11
H-1a, 2
C-2, 3, 10
C-2, 11
-
21.80 (2H, m)33.2 (CH2)H-1aC-1, 3, 10, 11-
3-98.0 (C)---
4α
4β
3.14 (1H, d, 13.4)
2.28 (1H, d, 13.4)
49.2 (CH2)H-4β
H-4α
C-6, 10
C-2, 3, 5, 10
H-9α
-
5-107.4 (C)---
6α
6β
1.92 (1H, td, 13.2, 4.2)
2.06 (1H, m)
39.3 (CH2)H-6β, 7β
H-6α,7α
C-5, 7, 8
C-4, 5, 8
-
7α
7β
2.29 (1H, m)
2.44 (1H, td, 13.1, 2.8)
29.1 (CH2)H-6β, 7β
H-6α,7α
C-5, 6, 8, 9, 15
C-5, 6, 8, 15
-
8-149.4 (C)---
9α
9β
2.04 (1H, m)
2.55 (1H, brd, 17.1)
40.8 (CH2)H-9β, 10
H-9α, 10, 15a, 15b
C-3, 7, 8, 10, 11, 15
-
H-4α, 11
H-10
102.39 (1H, m)46.8 (CH)H-9α, 9β, 11C-3, 9, 11, 12H-9β, 12, 13
111.31 (1H, m)54.3 (CH)H-1a, 10, 12C-1, 9, 10, 12, 13, 14H-9α
121.65 (1H, m)32.8 (CH)H-11, 13, 14C-1, 10, 11, 13, 14H-10
130.95 (3H, d, 6.7)22.0 (CH3)H-12C-11, 12, 14H-10
140.89 (3H, d, 6.7)20.1 (CH3)H-12C-11, 12, 13-
15a
15b
4.90 (1H, brs)
4.93 (1H, brs)
113.0 (CH2)H-9β
H-9β
C-7, 9
C-7, 9
-
a Spectrum recorded at 500 MHz in CDCl3. b Spectrum recorded at 125 MHz in CDCl3.
Table 2. NMR spectral data of compound 2.
Table 2. NMR spectral data of compound 2.
No.δH (J in Hz) aδC (TYPE) b1H-1H COSYHMBCNOE
11.91 (1H, m)
1.53 (1H, m)
23.9 (CH2)H-2, 10C-2, 9, 10-
22.24 (1H, m)
1.57 (1H, m)
33.3 (CH2)H-1C-1, 3, 14-
3-60.3 (C)---
4-213.2 (C)---
52.56 (1H, ddd, 13.5, 7.0, 2.5)
2.43 (1H, dd, 13.5, 2.8)
38.0 (CH2)H-6C-4, 6, 7-
63.00 (1H, ddd, 15.6, 7.1, 3.2)
2.05(1H, m)
20.1 (CH2)H-5C-4, 5, 7, 8, 15
-
-
7-143.7 (C)---
86.78(1H, dd, 4.8, 1.8)157.4 (CH)H-9C-3, 6, 9, 10, 15-
92.48 (1H, dd, 10.4, 4.3)49.0 (CH)H-8, 10C-3, 4, 7, 8, 10, 11H-14
102.08 (1H, m)49.4 (CH)H-1, 9, 11C-1, 8, 9, 11, 12, 13H-14
111.67 (1H, m)31.5 (CH)H-10, 12, 13C-1, 9, 10, 12, 13-
120.88 (3H, d, 6.7)18.9 (CH3)H-11C-10, 11, 13-
130.93 (3H, d, 6.7)21.5 (CH3)H-11C-10, 11, 12-
141.02 (3H, s)19.5 (CH3)-C-2, 3, 4, 9H-9, 10
159.49 (1H, s)192.7 (CH)-C-6, 7-
a Spectrum recorded at 500 MHz in CDCl3. b Spectrum recorded at 125 MHz in CDCl3.
Table 3. NMR spectral data of compound 3.
Table 3. NMR spectral data of compound 3.
No.δH (J in Hz) aδC (Type) b1H-1H COSYHMBCNOE
1-213.0 (C)---
22.66 (1H, m)
2.41 (1H, m)
38.3 (CH2)H-3C-1, 3-
32.60 (1H, m)
2.39 (1H, m)
35.3 (CH2)H-2C-1, 2, 4, 5, 15-
4-142.9 (C)---
52.21 (1H, d, 9.9)54.9 (CH)H-6C-1, 3, 4, 6, 9, 10, 14, 15H-7
64.17 (1H, dd, 9.9, 9.9)68.7 (CH)H-5, 7C-4, 5, 7, 11H-13, 14
71.55 (1H, td, 9.6, 3.5)52.7 (CH)H-6, 8C-6, 8, 11H-5
81.73 (1H, ddd, 10.5, 6.6, 3.3)
1.14 (1H, ddd, 26.7, 13.4, 3.4)
21.9 (CH2)H-7, 9C-7, 10-
91.78 (1H, dt, 13.7, 3.0)
1.62 (1H, td, 13.8, 3.6)
31.5 (CH2)H-8C-8, 10-
10-49.8 (C)---
11-74.6 (C)---
121.26 (3H, s)30.0 (CH3)-C-7, 11, 13-
131.30 (3H, s)24.1 (CH3)-C-7, 11, 12H-6
141.01 (3H, s)17.9 (CH3)-C-1, 5, 9, 10H-6
155.28 (1H, s)
5.05 (1H, s)
110.6 (CH2)H-5C-3, 4, 5-
a Spectrum recorded at 500 MHz in CDCl3. b Spectrum recorded at 125 MHz in CDCl3.
Table 4. NMR spectral data of compound 4.
Table 4. NMR spectral data of compound 4.
No.δH (J in Hz) aδC (Type) b1H-1H COSYHMBCNOESY
12.49 (1H, m)44.1 (CH)H-2, 14C-2H-9β
23.12 (1H, dd, 15.1, 3.0)
3.07 (1H, dd, 15.1, 8.6)
30.6 (CH2)H-1C-1, 3, 4, 14, 15-
3-161.0 (C)---
4-114.6 (C)---
56.63 (1H, s)112.2 (CH)-C-3, 4, 6H-19
6-149.0 (C)---
74.07 (1H, s)83.7 (CH)-C-5, 8, 9, 19, 22H-5, 19
8-73.1 (C)---
9α
9β
2.47 (1H, d, 17.8)
3.19 (1H, d, 17.8)
46.0 (CH2)-C-7, 8, 10, 19H-19
H-1
10-208.6 (C)---
11a
11b
3.60 (1H, d, 18.2)
3.55 (1H, d, 18.1)
42.0 (CH2)-C-10, 12, 13, 20-
H-14
12-125.1 (C)---
136.96 (1H, dd, 11.0, 4.0)144.1 (CH)H-14C-1, 11, 14, 20-
14a
14b
2.45 (1H, m)
2.28 (1H, m)
31.4 (CH2)H-1, 13C-1, 2, 12, 13, 15H-11
-
15-145.9 (C)---
164.87 (1H, s)
4.79 (1H, s)
111.4 (CH2)H-17C-1, 15, 17-
171.81 (3H, s)20.8 (CH3)H-16C-1, 15, 16-
18-164.0 (C)---
191.35 (3H, s)27.9 (CH3)-C-7, 8, 9H-7, 9α
20-167.3 (C)---
213.79 (3H, s)51.4 (-OCH3)-C-18-
223.26 (3H, s)57.8 (-OCH3)-C-7-
233.72 (3H, s)52.1 (-OCH3)-C-20-
a Spectrum recorded at 500 MHz in CDCl3. b Spectrum recorded at 125 MHz in CDCl3.
Table 5. NMR spectral data of compound 5.
Table 5. NMR spectral data of compound 5.
No.δH (J in Hz) aδC (Type) b1H-1H COSYHMBCNOESY
12.90 (1H, m)38.9 (CH)H-2, 14C-2H-2β
2α
β
2.70 (1H, m)
2.37 (1H, m)
44.3 (CH2)H-1C-1, 3, 4-
H-1, 4β
3-207.1 (C)---
4β
α
2.80 (1H, m)2.39 (1H, m)46.5 (CH2)H-5C-3, 5H-5, 2β
-
54.32 (1H, brd, 11.1)76.8 (CH)H-4C-3, 4, 6H-4β, 7β
6-212.1 (C)---
7β
α
2.67 (1H, m)
2.43 (1H, m)
48.8 (CH2)-C-6, 8, 9, 18H-5
H-18
8-79.8 (C)---
92.82 (1H, m)
2.40 (1H, m)
50.7 (CH2)-C-7, 8, 10, 18-
10-205.7 (C)---
11a
11b
3.51 (1H, d, 17.6)
3.44 (1H, d, 17.7)
43.5 (CH2)-C-10, 12, 13, 19-
H-14
12-128.6 (C)---
136.80 (1H, dd, 7.0, 7.0)140.9 (CH)H-14C-1, 11, 12, 19-
142.27 (2H, m)28.8 (CH2)H-1, 13C-1, 2, 12, 13, 15H-11b
15-144.9 (C)---
16a
b
4.95 (1H, s)
4.75 (1H, s)
112.2 (CH2)H-17C-1, 15, 17-
171.75 (CH3, s)21.2 (CH3)-C-1, 15, 16-
181.41 (CH3, s)27.5 (CH3)-C-7, 8, 9H-7β
19-167.3 (C)---
203.71 (CH3, s)52.0 (CH3)-C-19-
a Spectrum recorded at 500 MHz in CDCl3. b Spectrum recorded at 125 MHz in CDCl3.

Share and Cite

MDPI and ACS Style

Qin, G.-F.; Tang, X.-L.; Sun, Y.-T.; Luo, X.-C.; Zhang, J.; Van Ofwegen, L.; Sung, P.-J.; Li, P.-L.; Li, G.-Q. Terpenoids from the Soft Coral Sinularia sp. Collected in Yongxing Island. Mar. Drugs 2018, 16, 127. https://doi.org/10.3390/md16040127

AMA Style

Qin G-F, Tang X-L, Sun Y-T, Luo X-C, Zhang J, Van Ofwegen L, Sung P-J, Li P-L, Li G-Q. Terpenoids from the Soft Coral Sinularia sp. Collected in Yongxing Island. Marine Drugs. 2018; 16(4):127. https://doi.org/10.3390/md16040127

Chicago/Turabian Style

Qin, Guo-Fei, Xu-Li Tang, Yan-Ting Sun, Xiang-Chao Luo, Jing Zhang, Leen Van Ofwegen, Ping-Jyun Sung, Ping-Lin Li, and Guo-Qiang Li. 2018. "Terpenoids from the Soft Coral Sinularia sp. Collected in Yongxing Island" Marine Drugs 16, no. 4: 127. https://doi.org/10.3390/md16040127

APA Style

Qin, G. -F., Tang, X. -L., Sun, Y. -T., Luo, X. -C., Zhang, J., Van Ofwegen, L., Sung, P. -J., Li, P. -L., & Li, G. -Q. (2018). Terpenoids from the Soft Coral Sinularia sp. Collected in Yongxing Island. Marine Drugs, 16(4), 127. https://doi.org/10.3390/md16040127

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop